These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 35064230)

  • 1. Why scientists are racing to develop more COVID antivirals.
    Kozlov M
    Nature; 2022 Jan; 601(7894):496. PubMed ID: 35064230
    [No Abstract]   [Full Text] [Related]  

  • 2. Antiviral pills could change pandemic's course.
    Couzin-Frankel J
    Science; 2021 Nov; 374(6569):799-800. PubMed ID: 34762459
    [No Abstract]   [Full Text] [Related]  

  • 3. Hundreds of COVID trials could provide a deluge of new drugs.
    Ledford H
    Nature; 2022 Mar; 603(7899):25-27. PubMed ID: 35233098
    [No Abstract]   [Full Text] [Related]  

  • 4. Treatment of COVID-19 in high-risk outpatients.
    Med Lett Drugs Ther; 2022 Feb; 64(1643):e1. PubMed ID: 35134051
    [No Abstract]   [Full Text] [Related]  

  • 5. The race for antiviral drugs to beat COVID - and the next pandemic.
    Dolgin E
    Nature; 2021 Apr; 592(7854):340-343. PubMed ID: 33854246
    [No Abstract]   [Full Text] [Related]  

  • 6. Audio Interview: A Potential New Agent to Treat Covid-19.
    Rubin EJ; Baden LR; Morrissey S
    N Engl J Med; 2021 Dec; 385(26):e101. PubMed ID: 34936745
    [No Abstract]   [Full Text] [Related]  

  • 7. COVID-19 Therapeutics for Nonhospitalized Patients.
    Gandhi RT; Malani PN; Del Rio C
    JAMA; 2022 Feb; 327(7):617-618. PubMed ID: 35029659
    [No Abstract]   [Full Text] [Related]  

  • 8. An updated practical guideline on use of molnupiravir and comparison with agents having emergency use authorization for treatment of COVID-19.
    Singh AK; Singh A; Singh R; Misra A
    Diabetes Metab Syndr; 2022 Feb; 16(2):102396. PubMed ID: 35051686
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A National Strategy for COVID-19 Medical Countermeasures: Vaccines and Therapeutics.
    Borio LL; Bright RA; Emanuel EJ
    JAMA; 2022 Jan; 327(3):215-216. PubMed ID: 34989782
    [No Abstract]   [Full Text] [Related]  

  • 10. An oral SARS-CoV-2 M
    Owen DR; Allerton CMN; Anderson AS; Aschenbrenner L; Avery M; Berritt S; Boras B; Cardin RD; Carlo A; Coffman KJ; Dantonio A; Di L; Eng H; Ferre R; Gajiwala KS; Gibson SA; Greasley SE; Hurst BL; Kadar EP; Kalgutkar AS; Lee JC; Lee J; Liu W; Mason SW; Noell S; Novak JJ; Obach RS; Ogilvie K; Patel NC; Pettersson M; Rai DK; Reese MR; Sammons MF; Sathish JG; Singh RSP; Steppan CM; Stewart AE; Tuttle JB; Updyke L; Verhoest PR; Wei L; Yang Q; Zhu Y
    Science; 2021 Dec; 374(6575):1586-1593. PubMed ID: 34726479
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Remdesivir, Molnupiravir and Nirmatrelvir remain active against SARS-CoV-2 Omicron and other variants of concern.
    Vangeel L; Chiu W; De Jonghe S; Maes P; Slechten B; Raymenants J; André E; Leyssen P; Neyts J; Jochmans D
    Antiviral Res; 2022 Feb; 198():105252. PubMed ID: 35085683
    [TBL] [Abstract][Full Text] [Related]  

  • 12. COVID is here to stay: countries must decide how to adapt.
    Nature; 2022 Jan; 601(7892):165. PubMed ID: 35013606
    [No Abstract]   [Full Text] [Related]  

  • 13. Bad news for Paxlovid? Resistance may be coming.
    Service RF
    Science; 2022 Jul; 377(6602):138-139. PubMed ID: 35857562
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Patients.
    Parums DV
    Med Sci Monit; 2022 Jan; 28():e935952. PubMed ID: 34972812
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nirmatrelvir-Ritonavir and Viral Load Rebound in Covid-19.
    Anderson AS; Caubel P; Rusnak JM;
    N Engl J Med; 2022 Sep; 387(11):1047-1049. PubMed ID: 36069818
    [No Abstract]   [Full Text] [Related]  

  • 16. Rehospitalization, Emergency Visits After Paxlovid Treatment Are Rare.
    Kuehn BM
    JAMA; 2022 Jul; 328(4):323. PubMed ID: 35881113
    [No Abstract]   [Full Text] [Related]  

  • 17. Paxlovid for treatment of COVID-19.
    Med Lett Drugs Ther; 2022 Jan; 64(1642):9-10. PubMed ID: 35134040
    [No Abstract]   [Full Text] [Related]  

  • 18. Lethal mutagenesis as an antiviral strategy.
    Swanstrom R; Schinazi RF
    Science; 2022 Feb; 375(6580):497-498. PubMed ID: 35113690
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exploring the Binding Mechanism of PF-07321332 SARS-CoV-2 Protease Inhibitor through Molecular Dynamics and Binding Free Energy Simulations.
    Ahmad B; Batool M; Ain QU; Kim MS; Choi S
    Int J Mol Sci; 2021 Aug; 22(17):. PubMed ID: 34502033
    [TBL] [Abstract][Full Text] [Related]  

  • 20. COVID-19: LMICs need antivirals as well as vaccines.
    Bajaj SS; Stanford FC
    Nature; 2022 Feb; 602(7895):33. PubMed ID: 35105995
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.